Ke has been a part of the Shah Capital team since 2006. He is responsible for assisting with research and analysis of existing as well as potential future investment holdings in Greater China region. His role includes detailed monitoring of strategies and progress of companies within our investment portfolio while aiming to uncover new and profitable investment ideas.

Prior to joining Shah Capital, Ke had worked as a Scientist with Pfizer, Eli Lilly, and biotech startup Amphora Discovery. Ke holds a MBA from Kenan-Flagler Business School at UNC Chapel Hill, also holds M.S. in Chemistry from University of Florida, and earned his B.S. from University of Science and Technology of China.